ConverSant R&D SRL
ConverSant R&D reported total assets of 131,724 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Jul 2026).
The score of ConverSant R&D shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +629 % Total assets +399 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ConverSant R&D's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Jul 2026
- Year ended 31 Dec 2024filed on 29 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
ConverSant R&D's financial analysis
- Solvency87.7%sector median: 55.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ConverSant R&D
ConverSant R&D's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0805.558.967
- VAT number
- BE0805558967
- Peppol
- Registered · 0208:0805558967 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Sep 2023
- Registered office
- 9620 Zottegem
- Latest accounts
- 2025 · filed on 28 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
ConverSant R&D (SRL) has been based in Zottegem since 2023, active in: other business support service activities n.e.c.. For 2025, it reports a net profit of 6,622 € and equity of 115,574 €; its revenue is not published. Its solvency stands at 87.7%, above the median of its sector (55.4%).
Companies similar to ConverSant R&D
Companies in the same business, of comparable size and area, outside its group.
- Jedebo Other business support service activities n.e.c. Menen · balance sheet 101,390 €
- Proces Optimization Other business support service activities n.e.c. Schoten · balance sheet 128,951 €
- Groupe Grandjean LUX Other business support service activities n.e.c. Bastogne · balance sheet 124,457 €
- Borre Other business support service activities n.e.c. Heist-op-den-Berg · balance sheet 118,965 €
- Finanza Other business support service activities n.e.c. Genk · balance sheet 156,893 €
- Agnomen Other business support service activities n.e.c. Ghent · balance sheet 132,899 €
- Algemene Assistentie en Trading Other business support service activities n.e.c. Antwerp · balance sheet 141,270 €
- EDA Other business support service activities n.e.c. Oudenaarde · balance sheet 166,507 €
Frequently asked questions about ConverSant R&D
What is the revenue of ConverSant R&D?
ConverSant R&D files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ConverSant R&D?
In Belgium, the VAT number is the company number prefixed with BE: BE0805558967 for ConverSant R&D, if the company is VAT-registered. Its company number (CBE) is 0805.558.967.
Where is the registered office of ConverSant R&D?
According to the CBE register, the registered office of ConverSant R&D is in 9620 Zottegem.
What is the equity of ConverSant R&D?
At the close of the 2025 financial year, the equity of ConverSant R&D amounts to 115,574 €, a solvency of 87.7% of total assets.
Who manages ConverSant R&D?
The register lists 1 active mandates at ConverSant R&D. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ConverSant R&D
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →